Gene therapy technique slows ALD brain disease

November 5, 2009
Gene therapy technique slows brain disease

Enlarge

Progeny of HSCs that were engineered to carry the correct version of a gene (through the integration of a lentiviral vector) distribute throughout the body. Cartier et al. show that some cells replaced diseased microglia in the brain and relieved lipid storage in patients suffering from ALD. Credit: Image courtesy of Y. Greenman/Science

A strategy that combines gene therapy with blood stem cell therapy may be a useful tool for treating a fatal brain disease, French researchers have found. These findings appear in the 6 November 2009 issue of the journal Science.

In a pilot study of two patients monitored for two years, an international team of researchers slowed the onset of the debilitating brain disease X-linked adrenoleukodystrophy (ALD) using a lentiviral vector to introduce a therapeutic gene into patient's blood cells. Although studies with larger cohorts of patients are needed, these results suggest that with lentiviral vectors, which are derived from disabled versions of (HIV), could potentially become instrumental in treating a broad range of human disorders.

"This is the first time we were able to successfully use an HIV-derived lentivirus vector for gene therapy in humans, and also the first time that a very severe brain disease has been treated with efficacy by gene therapy. We've demonstrated that this HIV-derived lentivirus vector works as was hoped for so many years," said coauthor Patrick Aubourg, professor of pediatrics at University Paris-Descartes and head of a research unit at Inserm-University Paris Descartes.

Featured in the movie "Lorenzo's Oil," ALD is a severe hereditary condition caused by a deficiency of a protein called ALD that is involved in fatty acid degradation. Sufferers steadily lose their myelin sheath, the protective layer that coats nerve fibers in the brain. Without myelin the nerves lose function, leading to increasing physical and mental disability in patients. X-linked ALD, the most common form of the disease, affects boys starting at age 6-8 years of age and death usually occurs before the patients reach adolescence.

transplants typically slow progression of the disease because the donor marrow includes cells that develop into myelin-producing cells. However, finding a matching bone marrow donor can be a challenging and lengthy process, and the procedure carries considerable risks.

Genetically correcting the blood stem cells in the patients' own bone marrow may prove to be a valuable alternative approach when no matched donors are available.

Gene therapy technique slows brain disease
Enlarge

This figure represents four cells, four purified CD34+ (the CD34+ cell population comprises true hematopoetic stem cell) from patient P1. These cells were sampled/purifed from his bone marrow 2 years after gene therapy. The blue circles represent nucleus of cells. The red dots in one cell are peroxisomes (intracellular organelle) in which the ALD protein encoded by the integrated lentiviral vector is expressed. In other cells, the red dots are not detectable because these cells are not corrected after gene therapy and the mutation of ABCD1 gene in this patient results in complete absence of ALD protein expression in peroxisomes. The exact ratio of corrected/non-corrected CD34% cells in patient P1, two years after gene therapy, is 18 percent. Credit: Image courtesy of Patrick Aubourg

In most gene therapy studies, a working gene is inserted into the genome to replace a dysfunctional, disease-causing gene. A carrier molecule called a vector is used to deliver the therapeutic gene into the patient's cells. Vectors are typically the backbones of viruses that have been genetically altered to carry normal human DNA. Scientists have recently turned to vectors based on the lentivirus genus of retroviruses, which includes HIV. Lentiviral vectors are a type of retrovirus that can infect both dividing and nondividing cells, and are thought to provide long-term and stable gene expression, unlike other retroviruses.

"The HIV-derived lentivirus vector allows expression of the therapeutic gene in principle for life, because the therapeutic gene is inserted in the chromosomes—the genome. Therefore, cells that derive from the initially corrected cells, stem cells in particular, will continue to express the therapeutic gene forever," said Aubourg.

In the study, blood stem cells were removed from the patients and genetically corrected in the lab, using a lentiviral vector to introduce a working copy of the ALD gene into the cells. The modified cells were then infused back into the patients' after they had received a treatment that destroyed their bone marrow. Two years later, healthy ALD proteins were still detectable in both patients' blood cells. Encouragingly, both patients showed neurological improvement and a delay in disease progression comparable to that seen with bone marrow transplants.

The healthy ALD protein was expressed in about 15 percent of blood cells, yet surprisingly this low level was sufficient to slow in ALD. "This percentage of correction will not be sufficient for all diseases," warns Aubourg. "There is a lot of work to be done to make this gene therapy vector more powerful, less complicated, and less expensive. This is only the beginning," he said.

Gene therapy is not without serious risks. Like other retrovirus vectors, the HIV-derived lentivirus vector is tasked with inserting the therapeutic gene in the chromosomes of the patients' cells. In a worst case scenario, this action could disturb the biology of the cells and patients could end up with leukemia; this outcome has occurred in past gene therapy trials. "The HIV-derived lentivirus vector basically has this same risk, although the design of the vector makes patients less prone to this side effect," said Aubourg.

More information: Science paper, "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-linked Adrenoleukodystrophy," by Dr. Nathalie Cartier et al.

Source: American Association for the Advancement of Science


Rank 5 /5 (1 vote)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Researchers illuminate link between sodium, calcium and heartbeat

Using the Canadian Light Source synchrotron, researchers from the University of British Columbia have revealed, for the first time, one of the molecular mechanisms that regulates the beating of heart cells by controlling ...

Medicine & Health / Research

created 56 minutes ago | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

Oxygen-deprived baby rats fare worse if kept warm

New study suggests that baby rats deprived of oxygen, but kept warm, had bigger swings in glucose and insulin, metabolic and physiologic effects that could increase the chances of brain damage. Findings could have implications ...

Medicine & Health / Research

created 58 minutes ago | popularity not rated yet | comments 0

Fetal exposure to radiation increases risk of testicular cancer

Male fetuses of mothers that are exposed to radiation during early pregnancy may have an increased chance of developing testicular cancer, according to a study in mice at The University of Texas MD Anderson Cancer Center. ...

Medicine & Health / Cancer

created 17 minutes ago | popularity not rated yet | comments 0

Prolonged fructose intake not linked to rise in blood pressure

Eating fructose over an extended period of time does not lead to an increase in blood pressure, according to researchers at St. Michael's Hospital.

Medicine & Health / Health

created 47 minutes ago | popularity not rated yet | comments 0

Challenges of identifying cognitive abilities in severely brain-injured patients

Only by employing complex machine-learning techniques to decipher repeated advanced brain scans were researchers at NewYork-Presbyterian/Weill Cornell able to provide evidence that a patient with a severe brain injury could, ...

Medicine & Health / Neuroscience

created 37 minutes ago | popularity not rated yet | comments 0


Music service gives Myspace second wind

Faded online social network Myspace said Monday it was getting a second wind due to the popularity of a freshly launched online music player.

Computer programs that think like humans

Intelligence – what does it really mean? In the 1800s, it meant that you were good at memorising things, and today intelligence is measured through IQ tests where the average score for humans is 100. ...

Study shows children with IBD have difficulty in school, mostly due to absences

Children with inflammatory bowel disease (IBD) may have difficulty functioning in school, particularly because their tendency to internalize problems can impact attendance. These are the findings from a Nationwide Children's ...

Fast photon control brings quantum photonic technologies closer

(PhysOrg.com) -- Using photons instead of electrons to transmit information could lead to faster and more secure ways to communicate, among other advantages. Now a team of physicists has taken another step toward realizing ...

Brain-imaging technique predicts who will suffer cognitive decline over time

Cognitive loss and brain degeneration currently affect millions of adults, and the number will increase, given the population of aging baby boomers. Today, nearly 20 percent of people age 65 or older suffer ...

Neuron memory key to taming chronic pain

For some, the pain is so great that they can't even bear to have clothes touch their skin. For others, it means that every step is a deliberate and agonizing choice. Whether the pain is caused by arthritic joints, an injury ...